WorldNetDaily

The U.S. government is investigating a Chinese manufacturing plant as a possible source of the problems with a Baxter International brand name blood thinner that has been linked to four deaths and hundreds of allergic reactions.

According to a report by the Associated Press, the Food and Drug Administration is looking into “all possible sources of the problem” that has developed in recent weeks with the use of the drug heparin, which is sold by Baxter and used by patients in danger of having their blood clot.

Erin Gardiner, a spokeswoman for Baxter, told AP her company buys the active ingredient for heparin from a company that makes it both at a Chinese factory as well as a facility inside the United States…

Click here to read entire story